Evaluating the influence of oleic and palmitic acids on inflammatory markers and gut barrier integrity in a celiac disease Caco-2 model
Molecular Biology Reports · 2025
DOI: 10.1007/s11033-025-11044-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Behrooz Ahmadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Celiac Disease, Palmitic Acid, Oleic Acid, Palmitic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND AND AIM: The fatty acid (FA) composition of the gluten-free diet (GFD) may affect mucosal responses in celiac disease (CeD). This study evaluated the effects of oleic acid (OA) and palmitic acid (PA) on gliadin-induced inflammation and barrier dysfunction using Caco-2 cells. METHODS: Caco-2 cells were cultured under standard conditions and exposed to peptic-tryptic digested gliadin (PT-Gliadin) to induce a CeD-like response. Cells were treated with OA or PA under three conditions: co-treatment (with PT-Gliadin), pre-treatment (before PT-Gliadin), or post-treatment (after PT-Gliadin). Inflammatory gene expression (NF-κB, TNF-α, IL-6, IL-15) and tight junction markers (ZO-1, occludin) were quantified by qRT-PCR, while IL-6 and IL-15 secretion was measured by ELISA. RESULTS: PT-Gliadin significantly increased inflammatory gene expression and cytokine secretion, while reducing ZO-1 and occludin levels (p < 0.05). OA co-treatment significantly suppressed NF-κB, TNF-α, IL-6, and IL-15 expression, lowered IL-6 and IL-15 secretion, and increased ZO-1 and occludin levels (p < 0.05). OA post-treatment also reduced NF-κB and IL-15 expression (p < 0.05) and diminished both IL-6 and IL-15 release (p < 0.05). Conversely, PA co-treatment elevated NF-κB, TNF-α, IL-6, and IL-15 expression (p < 0.05), increased IL-6 secretion (p < 0.05), and aggravated the loss of ZO-1 and occludin (p < 0.05). PA post-treatment similarly enhanced NF-κB, TNF-α, IL-6, and IL-15 expression (p < 0.05), increased IL-6 secretion (p < 0.05), and reduced occludin level (p < 0.05). Pre-treatment with either FA produced no significant effects. CONCLUSION: OA mitigates, whereas PA exacerbates, gliadin-induced inflammation and barrier damage in Caco-2 cells. Modifying GFD fat composition to favor OA over PA may improve mucosal outcomes in CeD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Celiac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Celiac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. m.rostamii@gmail.com.
Zitieren
APA
Ahmadi, B., Nikzamir, A., Sirati-Sabet, M., Asri, N., & Rostami-Nejad, M. (2025). Evaluating the influence of oleic and palmitic acids on inflammatory markers and gut barrier integrity in a celiac disease Caco-2 model. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-11044-7
Vancouver
Ahmadi B, Nikzamir A, Sirati-Sabet M, Asri N, Rostami-Nejad M. Evaluating the influence of oleic and palmitic acids on inflammatory markers and gut barrier integrity in a celiac disease Caco-2 model. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-11044-7
BibTeX
@article{Ahmadi2025,
author = {Ahmadi, Behrooz and Nikzamir, Abdolrahim and Sirati-Sabet, Majid and Asri, Nastaran and Rostami-Nejad, Mohammad},
title = {Evaluating the influence of oleic and palmitic acids on inflammatory markers and gut barrier integrity in a celiac disease Caco-2 model},
journal = {Molecular Biology Reports},
year = {2025},
doi = {10.1007/s11033-025-11044-7}
}
EUVIMED